Episode

Ep. 206: Genetics in ALS and frontotemporal dementia – from pathophysiology to treatment

Podcast
eanCast: Weekly Neurology
Published
Jun 21, 2026
Duration seconds
1194
Processing state
not_requested
Canonical source
https://eancast.podigee.io/206-neue-episode
Audio
https://audio.podigee-cdn.net/2516790-m-0413d9b3f68285c215143eb5d42e0d18.mp3?source=feed
JSON
/v1/public/podcasts/eancast-weekly-neurology-5497158/episodes/ep-206-genetics-in-als-and-frontotemporal-dementia-from-pathophysiology-to-treatment
Markdown
/podcast/eancast-weekly-neurology-5497158/ep-206-genetics-in-als-and-frontotemporal-dementia-from-pathophysiology-to-treatment.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/eancast-weekly-neurology-5497158/episodes/ep-206-genetics-in-als-and-frontotemporal-dementia-from-pathophysiology-to-treatment/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/eancast-weekly-neurology-5497158/ep-206-genetics-in-als-and-frontotemporal-dementia-from-pathophysiology-to-treatment.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Moderator: Cláudia Santos Silva (Lisbon, Portugal) Guest: Andrea Calvo (Turin, Italy) In this episode, Cláudia Santos Silva speaks with Andrea Calvo about the genetics of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). They discuss the shared genetic basis of these disorders, key disease-associated genes, and the role of genetic testing, counselling, and result interpretation in clinical practice, highlighting how genetic discoveries are advancing precision medicine and emerging gene-targeted therapies in ALS and FTD.